NCT03009513View on ClinicalTrials.gov

Teneligliptin-Glimepiride DDI Study

PHASE1CompletedINTERVENTIONAL

Enrollment

26

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

May 31, 2017

Study Completion Date

June 30, 2017

Conditions

Diabetes Mellitus

Interventions

DRUG

Teneligliptin+Glimepiride

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Handok Inc.

INDUSTRY